Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have ... and Telix’s research and development programs; Telix ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis ... preclinical and clinical trials, and ...

and prostate cancer. He also spoke to more than a dozen experts who said that the administration’s actions could bring about long-lasting damage to cancer research — and that patients will die ...

Supporting a great cause, this particular Triumph Scrambler 1200 XE Icon Edition also boasts a unique bonus feature.

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary - Routine medical ...

Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

Semenax, manufactured by Leading Edge Health, is a supplement specifically designed to increase semen volume and intensify ...

An exclusive Triumph 1200 Icon Edition is set to be one of the top prizes in store for fundraisers in an upcoming charity motorcycle event. The ride-out event, called the Distinguished Gentleman’s ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.